Back to Search

NIALL HENEY, MB MD

MB MD

Urology Physician

NPI: 1134195639Individual

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

37668(MA)

Research & Publications (13)

Surgery: selective bladder-preserving therapy for muscle-invasive cancer.
PMID 19333224·Nat Rev Clin Oncol·2009
8-other
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2003. A 33-year-old woman with gross hematuria.
PMID 14681511·N Engl J Med·2003
5-case
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.
PMID 19636019·J Clin Oncol·2009
3-trial
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
PMID 19154448·BJU Int·2009
8-other
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
PMID 19100600·Urology·2009
3-trial
Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
PMID 19035903·BJU Int·2008
6-review
Bladder-sparing approaches to invasive disease.
PMID 17082940·World J Urol·2006
6-review
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
PMID 15890569·Int J Radiat Oncol Biol Phys·2005
8-other
Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.
PMID 14760367·Br J Cancer·2004
6-review
RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
PMID 14529770·Int J Radiat Oncol Biol Phys·2003
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
55 FRUIT STREET GRB 1102, DEPARTMENT OF UROLOGY
BOSTON, MA 02114

Quick Facts

NPI
1134195639
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
13

Are you this provider?

Claim Your Profile